dalteparin has been researched along with Fetal Death in 12 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Fetal Death: Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Between August 1 2000 and June 20 2007, 116 pregnant women with: (i) | 9.14 | Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. ( David, M; Demers, C; Garneau, P; Gauthier, R; Kahn, SR; Leduc, L; Magee, LA; Michon, N; Morin, F; Rey, E; Rodger, M, 2009) |
| "To evaluate the benefit of treatment with dalteparin and low-dose aspirin (ASA) in the prevention of obstetric complications in women with inherited thrombophilia." | 7.74 | Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. ( David, M; Dubois, E; Leduc, L; Rey, E; Takser, L, 2007) |
| "Between August 1 2000 and June 20 2007, 116 pregnant women with: (i) | 5.14 | Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. ( David, M; Demers, C; Garneau, P; Gauthier, R; Kahn, SR; Leduc, L; Magee, LA; Michon, N; Morin, F; Rey, E; Rodger, M, 2009) |
| " Low dose aspirin should be given to every pregnant woman with antiphospholipid antibodies, with the addition of low molecular weight heparin in those with previous thrombosis, previous fetal death or failure of monotherapy with aspirin." | 4.85 | [The antiphospholipid syndrome in the 21st century]. ( Egurbide, MV; Martinez-Berriotxoa, A; Ruiz-Irastorza, G, 2009) |
| "To evaluate the benefit of treatment with dalteparin and low-dose aspirin (ASA) in the prevention of obstetric complications in women with inherited thrombophilia." | 3.74 | Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. ( David, M; Dubois, E; Leduc, L; Rey, E; Takser, L, 2007) |
| "Gastrointestinal stromal tumors are the commonest stromal tumors of the digestive tract." | 1.36 | [Gastrointestinal stromal tumor in pregnancy and control. Case report]. ( Cuerva-González, MJ; de la Calle-Fernández, M; Lacoponi, S; Pozo-Krielinger, J, 2010) |
| "Inherited thrombophilia is associated with thromboembolic events and/or poor obstetric outcome." | 1.33 | Inherited thrombophilia: treatment during pregnancy. ( Caruso, A; De Carolis, S; De Stefano, V; Fatigante, G; Ferrazzani, S; Garofalo, S; Leone, G; Rossi, E, 2006) |
| "We studied the outcome of 41 pregnancies in an attempt to identify an appropriate and safe anticoagulant regimen for pregnant women with cardiac valve prosthesis." | 1.30 | Is there a safe anticoagulation protocol for pregnant women with prosthetic valves? ( Alam, SE; Arnaout, MS; Karam, K; Kazma, H; Khalil, A; Nasrallah, A; Shasha, N, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnaout, MS | 1 |
| Kazma, H | 1 |
| Khalil, A | 1 |
| Shasha, N | 1 |
| Nasrallah, A | 1 |
| Karam, K | 1 |
| Alam, SE | 1 |
| Vianello, A | 1 |
| Vencato, E | 1 |
| Cantini, M | 1 |
| Zanconato, G | 1 |
| Manfrin, E | 1 |
| Zamo, A | 1 |
| Zorzi, F | 1 |
| Mazzi, F | 1 |
| Martinelli, N | 1 |
| Cavaliere, E | 1 |
| Monari, F | 1 |
| Venturelli, D | 1 |
| Ferrara, F | 1 |
| Olivieri, O | 1 |
| De Franceschi, L | 1 |
| Ruiz-Irastorza, G | 1 |
| Martinez-Berriotxoa, A | 1 |
| Egurbide, MV | 1 |
| Sucak, A | 1 |
| Acar, K | 1 |
| Celen, S | 1 |
| Danisman, N | 1 |
| Sucak, GT | 1 |
| Cuerva-González, MJ | 1 |
| Lacoponi, S | 1 |
| de la Calle-Fernández, M | 1 |
| Pozo-Krielinger, J | 1 |
| Gris, JC | 1 |
| Mercier, E | 1 |
| Quéré, I | 1 |
| Lavigne-Lissalde, G | 1 |
| Cochery-Nouvellon, E | 1 |
| Hoffet, M | 1 |
| Ripart-Neveu, S | 1 |
| Tailland, ML | 1 |
| Dauzat, M | 1 |
| Marès, P | 1 |
| Thamban, S | 1 |
| Opemuyi, IO | 1 |
| Swinhoe, JR | 1 |
| Cochrane, GW | 1 |
| De Carolis, S | 1 |
| Ferrazzani, S | 1 |
| De Stefano, V | 1 |
| Garofalo, S | 1 |
| Fatigante, G | 1 |
| Rossi, E | 1 |
| Leone, G | 1 |
| Caruso, A | 1 |
| Macklon, NS | 1 |
| Greer, IA | 1 |
| Reid, AW | 1 |
| Walker, ID | 1 |
| Oles, D | 1 |
| Berryessa, R | 1 |
| Campbell, K | 1 |
| Bhatti, MA | 1 |
| Rey, E | 2 |
| Garneau, P | 1 |
| David, M | 2 |
| Gauthier, R | 1 |
| Leduc, L | 2 |
| Michon, N | 1 |
| Morin, F | 1 |
| Demers, C | 1 |
| Kahn, SR | 1 |
| Magee, LA | 1 |
| Rodger, M | 1 |
| Dubois, E | 1 |
| Takser, L | 1 |
2 reviews available for dalteparin and Fetal Death
| Article | Year |
|---|---|
[The antiphospholipid syndrome in the 21st century].
Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Tri | 2009 |
Gestational thrombocythaemia associated with intrauterine death: case report and a review of the literature.
Topics: Anticoagulants; Enoxaparin; Female; Fetal Death; Humans; Placenta; Placenta Diseases; Pregnancy; Pre | 2006 |
3 trials available for dalteparin and Fetal Death
| Article | Year |
|---|---|
Outcome of pregnancies in women with thrombophilic disorders.
Topics: Abortion, Habitual; Adult; Anticoagulants; Enoxaparin; Female; Fetal Death; Humans; Live Birth; Preg | 2010 |
Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.
Topics: Aspirin; Birth Weight; Enoxaparin; Female; Fetal Death; Folic Acid; Heparin, Low-Molecular-Weight; H | 2004 |
Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial.
Topics: Adult; Dalteparin; Female; Fetal Death; Humans; Infant, Low Birth Weight; Infant, Newborn; Pilot Pro | 2009 |
7 other studies available for dalteparin and Fetal Death
| Article | Year |
|---|---|
Is there a safe anticoagulation protocol for pregnant women with prosthetic valves?
Topics: Adult; Anticoagulants; Female; Fetal Death; Heart Valve Prosthesis; Heparin; Humans; Nadroparin; Obs | 1998 |
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis.
Topics: Abortion, Spontaneous; Adult; Anemia, Sickle Cell; Anticoagulants; Birth Weight; Cross-Sectional Stu | 2018 |
[Gastrointestinal stromal tumor in pregnancy and control. Case report].
Topics: Adult; Anticoagulants; Cesarean Section; Embolism, Amniotic Fluid; Emergencies; Enoxaparin; Female; | 2010 |
Inherited thrombophilia: treatment during pregnancy.
Topics: Adult; Anticoagulants; Birth Weight; Cesarean Section; Delivery, Obstetric; Enoxaparin; Female; Feta | 2006 |
Thrombocytopenia, antithrombin deficiency and extensive thromboembolism in pregnancy: treatment with low-molecular-weight heparin.
Topics: Adult; Antithrombin III; Antithrombin III Deficiency; Enoxaparin; Female; Fetal Death; Heparin; Huma | 1995 |
Emergency redo mitral valve replacement in a 27-year-old pregnant female with a clotted prosthetic mitral valve, preoperative fetal demise and postoperative ventricular assist device: a case report.
Topics: Adult; Anticoagulants; Blood Coagulation; Cardiac Surgical Procedures; Cerebral Hemorrhage; Enoxapar | 2001 |
Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia.
Topics: Abruptio Placentae; Adult; Anticoagulants; Aspirin; Dalteparin; Drug Therapy, Combination; Female; F | 2007 |